Neuberger Berman Group
LLY icon

Neuberger Berman Group’s Eli Lilly LLY Stock Holding History

Neuberger Berman Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.59B Sell
1,732,649
-44,142
-2% -$44.8M 1.21% 8
2025
Q4 		$1.91B Buy
1,776,791
+28,576
+2% +$27.3M 1.42% 8
2025
Q3 		$1.33B Buy
1,748,215
+192,240
+12% +$143M 0.97% 11
2025
Q2 		$1.21B Buy
1,555,975
+37,679
+2% +$29.3M 0.93% 10
2025
Q1 		$1.25B Buy
1,518,296
+60,882
+4% +$50.7M 1.05% 10
2024
Q4 		$1.13B Buy
1,457,414
+18,893
+1% +$15.6M 0.89% 12
2024
Q3 		$1.27B Sell
1,438,521
-11,027
-0.8% -$9.91M 0.99% 10
2024
Q2 		$1.31B Buy
1,449,548
+57,217
+4% +$45.8M 1.08% 8
2024
Q1 		$1.08B Sell
1,392,331
-54,729
-4% -$38.9M 0.9% 9
2023
Q4 		$844M Sell
1,447,060
-56,618
-4% -$33M 0.74% 14
2023
Q3 		$808M Buy
1,503,678
+35,344
+2% +$18.2M 0.74% 13
2023
Q2 		$689M Buy
1,468,334
+62,222
+4% +$26.1M 0.62% 23
2023
Q1 		$483M Buy
1,406,112
+75,211
+6% +$25.4M 0.45% 41
2022
Q4 		$487M Sell
1,330,901
-20,815
-2% -$7.38M 0.48% 38
2022
Q3 		$437M Sell
1,351,716
-20,985
-2% -$6.65M 0.46% 37
2022
Q2 		$445M Buy
1,372,701
+42,989
+3% +$12.9M 0.45% 41
2022
Q1 		$381M Buy
1,329,712
+34,396
+3% +$8.85M 0.32% 69
2021
Q4 		$355M Buy
1,295,316
+399,841
+45% +$101M 0.28% 87
2021
Q3 		$205M Sell
895,475
-29,700
-3% -$7.33M 0.18% 160
2021
Q2 		$211M Buy
925,175
+41,419
+5% +$8.32M 0.18% 157
2021
Q1 		$165M Sell
883,756
-68,319
-7% -$13.4M 0.16% 197
2020
Q4 		$161M Sell
952,075
-43,085
-4% -$6.43M 0.17% 179
2020
Q3 		$147M Buy
995,160
+27,246
+3% +$4.22M 0.17% 170
2020
Q2 		$159M Sell
967,914
-2,901
-0.3% -$445K 0.2% 141
2020
Q1 		$135M Buy
970,815
+32,585
+3% +$4.48M 0.21% 137
2019
Q4 		$123M Sell
938,230
-18,033
-2% -$2.09M 0.14% 215
2019
Q3 		$107M Sell
956,263
-193,809
-17% -$21.6M 0.13% 226
2019
Q2 		$127M Sell
1,150,072
-62,041
-5% -$7.31M 0.15% 192
2019
Q1 		$157M Sell
1,212,113
-148,187
-11% -$18M 0.19% 146
2018
Q4 		$157M Sell
1,360,300
-20,156
-1% -$2.25M 0.22% 130
2018
Q3 		$148M Buy
1,380,456
+57,056
+4% +$5.7M 0.17% 179
2018
Q2 		$113M Sell
1,323,400
-314
-0% -$25.8K 0.12% 237
2018
Q1 		$102M Sell
1,323,714
-899,554
-40% -$72.4M 0.12% 251
2017
Q4 		$188M Sell
2,223,268
-11,428
-0.5% -$972K 0.22% 142
2017
Q3 		$191M Sell
2,234,696
-81,835
-4% -$6.71M 0.24% 125
2017
Q2 		$191M Sell
2,316,531
-52,327
-2% -$4.27M 0.24% 122
2017
Q1 		$199M Buy
2,368,858
+221,724
+10% +$17.8M 0.26% 110
2016
Q4 		$158M Sell
2,147,134
-51,868
-2% -$3.86M 0.21% 149
2016
Q3 		$176M Sell
2,199,002
-620,344
-22% -$49.7M 0.24% 121
2016
Q2 		$222M Sell
2,819,346
-774,308
-22% -$58.3M 0.31% 82
2016
Q1 		$259M Buy
3,593,654
+17,432
+0.5% +$1.32M 0.36% 67
2015
Q4 		$301M Sell
3,576,222
-89,592
-2% -$7.43M 0.39% 57
2015
Q3 		$307M Sell
3,665,814
-366,705
-9% -$31M 0.4% 59
2015
Q2 		$337M Buy
4,032,519
+375,955
+10% +$28.6M 0.37% 59
2015
Q1 		$266M Buy
3,656,564
+285,593
+8% +$20.3M 0.28% 92
2014
Q4 		$233M Buy
3,370,971
+78,792
+2% +$5.32M 0.24% 122
2014
Q3 		$213M Buy
3,292,179
+75,456
+2% +$4.78M 0.22% 130
2014
Q2 		$200M Buy
3,216,723
+875,207
+37% +$52.2M 0.2% 148
2014
Q1 		$138M Buy
2,341,516
+2,188,454
+1,430% +$122M 0.14% 215
2013
Q4 		$7.81M Buy
153,062
+1,875
+1% +$93.9K 0.01% 849
2013
Q3 		$7.61M Buy
151,187
+51,414
+52% +$2.69M 0.01% 836
2013
Q2 		$4.9M Buy
+99,773
New +$5.43M 0.01% 886

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Neuberger Berman Group's LLY Position: Q1 2026 in Review

Neuberger Berman Group reduced its Eli Lilly (LLY) stake by 2.5% in Q1 2026, selling an estimated $44.8M and leaving 1,732,649 shares worth $1.59B. The position accounts for 1.21% of the portfolio, ranked #8.

Neuberger Berman Group first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.91B in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Neuberger Berman Group held 1,732,649 shares of Eli Lilly worth $1.59B as of Q1 2026.
  • Neuberger Berman Group sold 44,142 Eli Lilly shares in Q1 2026, an estimated $44.8M.
  • Eli Lilly made up 1.21% of Neuberger Berman Group's portfolio in Q1 2026, its #8 holding.
  • Neuberger Berman Group first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Neuberger Berman Group's Eli Lilly position peaked at $1.91B in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.